{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:06:48Z","timestamp":1791090408519,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.nbd.2010.03.019","type":"journal-article","created":{"date-parts":[[2010,4,19]],"date-time":"2010-04-19T09:05:31Z","timestamp":1271667931000},"page":"120-129","source":"Crossref","is-referenced-by-count":44,"title":["Phenothiazines interfere with dopaminergic neurodegeneration in Caenorhabditis elegans models of Parkinson's disease"],"prefix":"10.1016","volume":"40","author":[{"given":"Justyna B.","family":"Mocko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Moosmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Behl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvana","family":"Hajieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2010.03.019_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrn1868","article-title":"Expanding insights of mitochondrial dysfunction in Parkinson's disease","volume":"7","author":"Abou-Sleiman","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2010.03.019_bib2","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/0024-3205(85)90028-1","article-title":"A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum","volume":"37","author":"Andersen","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.nbd.2010.03.019_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/35072550","article-title":"Experimental models of Parkinson's disease","volume":"2","author":"Beal","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2010.03.019_bib4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000080983","article-title":"Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screenings","volume":"1","author":"Braungart","year":"2004","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.nbd.2010.03.019_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/genetics\/77.1.71","article-title":"The genetics of Caenorhabditis elegans","volume":"77","author":"Brenner","year":"1974","journal-title":"Genetics"},{"key":"10.1016\/j.nbd.2010.03.019_bib6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.nbd.2005.05.022","article-title":"Promethazine protects against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine neurotoxicity","volume":"20","author":"Cleren","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2010.03.019_bib7","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1468-1331.2008.02318.x","article-title":"Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy","volume":"15","author":"Cooper","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2010.03.019_bib8","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1523\/JNEUROSCI.2993-04.2004","article-title":"Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster","volume":"24","author":"Coulom","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2010.03.019_bib9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1474-4422(03)00501-5","article-title":"The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?","volume":"2","author":"Di Monte","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2010.03.019_bib10","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1073\/pnas.76.3.1333","article-title":"Analysis of the constancy of DNA sequences during development and evolution of the nematode Caenorhabditis elegans","volume":"76","author":"Emmons","year":"1979","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2010.03.019_bib11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1471-4159.2001.t01-1-00227.x","article-title":"Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss","volume":"77","author":"Grunblatt","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2010.03.019_bib12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1471-4159.2009.06114.x","article-title":"Novel imine antioxidants at low nanomolar concentrations protect dopaminergic cells from oxidative neurotoxicity","volume":"110","author":"Hajieva","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2010.03.019_bib13","series-title":"WormBook","article-title":"Behavior","author":"Hart","year":"2006"},{"key":"10.1016\/j.nbd.2010.03.019_bib14","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2144\/02324bm01","article-title":"PCR fusion-based approach to create reporter gene constructs for expression analysis in transgenic C. elegans","volume":"32","author":"Hobert","year":"2002","journal-title":"Biotechniques"},{"key":"10.1016\/j.nbd.2010.03.019_bib15","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1073\/pnas.68.10.2325","article-title":"Chlorpromazine and dopamine: conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs","volume":"68","author":"Horn","year":"1971","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2010.03.019_bib16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0006-2952(94)00424-K","article-title":"Characterization of the potential antioxidant and pro-oxidant actions of some neuroleptic drugs","volume":"49","author":"Jeding","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nbd.2010.03.019_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3233\/JAD-2008-15314","article-title":"Antioxidants in central nervous system diseases: preclinical promise and translational challenges","volume":"15","author":"Kamat","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2010.03.019_bib18","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.nbd.2010.03.019_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0091-679X(08)61381-3","article-title":"Basic culture methods","volume":"48","author":"Lewis","year":"1995","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.nbd.2010.03.019_bib20","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1242\/dev.126.24.5819","article-title":"Patterning of dopaminergic neurotransmitter identity among Caenorhabditis elegans ray sensory neurons by a TGFbeta family signaling pathway and a Hox gene","volume":"126","author":"Lints","year":"1999","journal-title":"Development"},{"key":"10.1016\/j.nbd.2010.03.019_bib21","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1212\/WNL.48.6.1583","article-title":"Environmental risk factors and Parkinson's disease: a case\u2013control study in Taiwan","volume":"48","author":"Liou","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2010.03.019_bib22","doi-asserted-by":"crossref","first-page":"12593","DOI":"10.1073\/pnas.93.22.12593","article-title":"A genetic selection for Caenorhabditis elegans synaptic transmission mutants","volume":"93","author":"Miller","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2010.03.019_bib23","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1471-4159.2005.03112.x","article-title":"Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q10","volume":"93","author":"Moon","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2010.03.019_bib24","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1517\/13543784.11.10.1407","article-title":"Antioxidants as treatment for neurodegenerative disorders","volume":"11","author":"Moosmann","year":"2002","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.nbd.2010.03.019_bib25","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1515\/BC.2001.195","article-title":"Protective activity of aromatic amines and imines against oxidative nerve cell death","volume":"382","author":"Moosmann","year":"2001","journal-title":"Biol. Chem."},{"key":"10.1016\/j.nbd.2010.03.019_bib26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev.pharmtox.43.100901.135934","article-title":"The Caenorhabditis elegans dopaminergic system: opportunities for insights into dopamine transport and neurodegeneration","volume":"43","author":"Nass","year":"2003","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.nbd.2010.03.019_bib27","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/archneur.59.11.1787","article-title":"Plantation work and risk of Parkinson disease in a population-based longitudinal study","volume":"59","author":"Petrovitch","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2010.03.019_bib28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/sj.emboj.7600057","article-title":"Dopamine modulates the plasticity of mechanosensory responses in Caenorhabditis elegans","volume":"23","author":"Sanyal","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2010.03.019_bib29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1021\/tx700210j","article-title":"Oxidative stress and neurotoxicity","volume":"21","author":"Sayre","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.nbd.2010.03.019_bib30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000101845","article-title":"Caenorhabditis elegans as a model system for Parkinson's disease","volume":"4","author":"Schmidt","year":"2007","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.nbd.2010.03.019_bib31","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","article-title":"Mechanism of toxicity in rotenone models of Parkinson's disease","volume":"23","author":"Sherer","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2010.03.019_bib32","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archneur.59.10.1541","article-title":"Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline","volume":"59","author":"Shults","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2010.03.019_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.20032053","article-title":"Clinically approved heterocyclics act on a mitochondrial target and reduce stroke-induced pathology","volume":"200","author":"Stavrovskaya","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2010.03.019_bib34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.molbrainres.2004.11.007","article-title":"Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures","volume":"134","author":"Testa","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2010.03.019_bib35","series-title":"C. elegans: A Practical Approach","first-page":"143","article-title":"Chapter 8: Neurobiology","author":"Thomas","year":"1999"},{"key":"10.1016\/j.nbd.2010.03.019_bib36","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1345\/aph.1G551","article-title":"Antioxidants, supplements, and Parkinson's disease","volume":"40","author":"Weber","year":"2006","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.nbd.2010.03.019_bib37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1600-0447.2008.01206.x","article-title":"Antipsychotic-induced movement disorders \u2014 forgotten but not gone","volume":"117","author":"Weiden","year":"2008","journal-title":"Acta Psychiatr. Scand."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996110000914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996110000914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T08:10:08Z","timestamp":1635235808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996110000914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0969996110000914"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2010.03.019","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}